Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomized, 2-armed phase-II-trial.
Nathalie AriansMatthias HäfnerJohannes KrisamKristin LangAntje WarkStefan A KoerberAdriane HommertgenJürgen DebusPublished in: BMC cancer (2020)
The trial is registered with clinicaltrials.gov (NCT04094454, 19.09.2019).